AstraZeneca Stock Nears Buy Point After Long Run In Declining Market

5 days ago

Share

AstraZeneca (AZN) is Thursday's pick for IBD 50 Growth Stocks To Watch as the biopharmaceutical name is holding up relatively well in a declining market. AstraZeneca stock is nearing a buy point after climbing for seven straight weeks. The IBD 50 drug stock is rising around 1.2% Thursday and outpacing the struggling major indexes. Some investors have looked outside the…


background

Stay Ahead with StockBurger!

Real-time meme stock trends powered by social media insights. Be the first to know about new market waves.

hand